TGA Fees and Charges Proposal 2026-27

The Therapeutic Goods Administration (TGA) is conducting a public consultation to provide industry and other interested stakeholders with an opportunity to comment on the TGA’s proposed fees and charges for the 2026-27 financial year. Specifically, we are seeking feedback on the potential impact/s of the proposed changes to fees and charges prior to seeking approval from the Government for any changes.

The TGA, within the Department of Health, Disability and Ageing, protects the health and safety of the community by regulating therapeutic goods for safety, efficacy, performance and quality. The TGA recovers its costs mostly from sponsors and manufacturers of therapeutic goods in accordance with Australian Government Charging Framework. The Therapeutic Goods Act 1989 provides the legal authority for the TGA to charge for its regulatory activities. The Therapeutic Goods (Charges) Act 1989 provides the legal authority to levy annual charges on sponsors and manufacturers of medicines, biologicals and medical devices.